"Arthritis, Rheumatic, & Bone Disease Associates - one of the most experienced rheumatology practices today. We pride ourselves on being devoted to patient care and understanding the underlying issues that cause disease. Our physicians specialize in treating a wide range of conditions including arthritis, autoimmune disease(s), musculoskeletal and joint pain, and osteoporosis."

During the past decade, Arthritis Rheumatic & Back Disease Associates conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 14 clinical trials were completed, i.e. on average, 155.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis Rheumatic & Back Disease Associates" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Anika Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis Rheumatic & Back Disease Associates" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis Rheumatic & Back Disease Associates" are "Rheumatoid Arthritis" (6 trials), "Arthritis, Psoriatic" (2 trials), "Arthritis, Rheumatoid" (2 trials), "Osteoarthritis" (2 trials) and "Osteoarthritis, Knee" (2 trials). Many other conditions were trialed in "Arthritis Rheumatic & Back Disease Associates" in a lesser frequency.

Most popular intervention types in "Arthritis Rheumatic & Back Disease Associates" are "Drug" (13 trials), "Biological" (4 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "CP-690,550" (2 trials), "Methotrexate" (2 trials), "NSAID" (2 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis Rheumatic & Back Disease Associates" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Arthritis Rheumatic & Back Disease Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Arthritis Rheumatic & Back Disease Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis Rheumatic & Back Disease Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".